[Clinical and electroencephalographic trial with clonazepam (Ro 5-4023) with special regard to status epilepticus].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy*; D005221:Fatigue / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D009574:Nitro Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D000927:Anticonvulsants; D001570:Benzodiazepinones; D002722:Chlorobenzenes; D009574:Nitro Compounds
Klinische und hirnelektrische Prüfung von Clonazepam (Ro 5-4023) unter besonderer Berücksichtigung des Status epilepticus.